Company
Zhuhai Hengqin ImStem Biotechnology Co., Ltd.
Zhuhai Hengqin ImStem Biotechnology Co., Ltd. has 1 drug tracked on RxWires: 1 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| IMS001 | Phase 1 | Multiple Sclerosis |
Latest
No recent events.
Follow Zhuhai Hengqin ImStem Biotechnology Co., Ltd. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.